Furlong Tammy 4
4 · Elevation Oncology, Inc. · Filed May 19, 2025
Insider Transaction Report
Form 4
Furlong Tammy
CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-05-15−300→ 2,100 total→ Common Stock (300 underlying) - Tax Payment
Common Stock
2025-05-15$0.30/sh−784$235→ 10,075 total - Exercise/Conversion
Restricted Stock Unit
2025-05-15−2,343→ 25,782 total→ Common Stock (2,343 underlying) - Exercise/Conversion
Common Stock
2025-05-15+2,643→ 10,859 total
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]25% of the RSUs vested on February 15, 2025, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
- [F3]The RSUs do not expire; they either vest or are canceled prior to the vesting date.
- [F4]25% of the RSUs vested on February 15, 2024, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.